- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Dense breast tissue.
Displaying page 1 of 1.
EudraCT Number: 2017-000317-22 | Sponsor Protocol Number: BRE-ASA01 | Start Date*: 2017-04-13 |
Sponsor Name:Linköping University | ||
Full Title: A pilot study of low dose acetylsalicylic acid (ASA) for reduction of breast density and inflammation | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002906-10 | Sponsor Protocol Number: BHR-700-301 | Start Date*: 2018-08-16 | |||||||||||
Sponsor Name:BHR Pharma, LLC | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women with BI-RADS Breast Density Categories C or D | |||||||||||||
Medical condition: Breast tissue density in women with BI-RADS Breast Density Categories C to D | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003459-31 | Sponsor Protocol Number: 2016/816 | Start Date*: 2016-10-10 |
Sponsor Name:Helse Bergen, Haukeland University Hospital | ||
Full Title: Treatment of patients with advanced breast cancer harboring TP53 mutations with dose-dense cyclophosphamide - the p53 trial | ||
Medical condition: Locally advanced breast cancer and metastatic breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003723-21 | Sponsor Protocol Number: BSMO-2014-01 | Start Date*: 2015-05-27 |
Sponsor Name:Belgian Society of Medical Oncology | ||
Full Title: A prospective, Belgian multi-center, single-arm, phase II study of neoadjuvant weekly paclitaxel and carboplatin followed by dose dense epirubicin and cyclophosphamide in stage II and III triple ne... | ||
Medical condition: Stage II and III triple negative breast cancer patients suitable for preoperative chemotherapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005214-11 | Sponsor Protocol Number: GBG-68 | Start Date*: 2012-08-10 | |||||||||||
Sponsor Name:GBG Forschungs GmbH | |||||||||||||
Full Title: Neo- / adjuvant phase III trial to compare intense dose-dense chemotherapy to tailored dose-dense chemotherapy in patients with high-risk early breast cancer (GAIN-2 trial) | |||||||||||||
Medical condition: Patients with primary breast cancer (now in neoadjuvant or adjuvant setting). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000189-45 | Sponsor Protocol Number: | Start Date*: 2018-03-26 |
Sponsor Name:University of Padova | ||
Full Title: Adjuvant treatment for high-risk triple negative breast cancer patients with the anti-pd-l1 antibody Avelumab: A phase III randomized trial | ||
Medical condition: High risk triple negative (ER negative, PR negative, HER2 negative) breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) IT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001868-11 | Sponsor Protocol Number: PELICAN-IPC2015-016 | Start Date*: 2017-09-08 | |||||||||||
Sponsor Name:Institut Paoli Calmettes | |||||||||||||
Full Title: A prospective, multicentre, open-label, randomized, phase II study of Pembrolizumab in combination with neoadjuvante (F)EC-Paclitaxel regimen in HER2-negative inflammatory breast cancer. | |||||||||||||
Medical condition: Inflammatory breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000619-14 | Sponsor Protocol Number: GBG84 | Start Date*: 2014-11-04 |
Sponsor Name:German Breast Group | ||
Full Title: A randomized phase III trial comparing two dose-dense, dose-intensified approaches (ETC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto) | ||
Medical condition: Patients with primary breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-005112-17 | Sponsor Protocol Number: IRFMN-BRC-7103 | Start Date*: 2017-07-11 | |||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | |||||||||||||
Full Title: Multicenter, randomized, phase II study of neoadjuvant chemotherapy associated or not with zoledronate and atorvastatin in triple negative breast cancers - YAPPETIZER Study | |||||||||||||
Medical condition: Triple Negative Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001881-40 | Sponsor Protocol Number: BO40747 | Start Date*: 2018-11-27 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A phase III, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Atezolizumab or placebo in combination with neoadjuvant doxorubicin + cyclophosphamid... | |||||||||||||
Medical condition: Early Human epidermal growth factor receptor 2 (HER2)-positive breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) ES (Temporarily Halted) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
